Portraying breast cancers with long noncoding RNAs

Science Advances

Volumn 2, Issue 9, 2016, Pages

  Van Grembergen, Olivier ^a   Bizet, Martin ^a   De Bony, Eric J ^a   Calonne, Emilie ^a   Putmans, Pascale ^a   Brohée, Sylvain ^b   Olsen, Catharina ^a   Guo, Mingzhou ^c   Bontempi, Gianluca ^a   Sotiriou, Christos ^b   Defrance, Matthieu ^a   Fuks, François ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b JULES BORDET INSTITUTE   (Belgium)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; CHEMICAL ACTIVATION; GENES; GROWTH KINETICS; MULTIVARIANT ANALYSIS; NUCLEIC ACIDS; TUMORS;

COMPREHENSIVE ANALYSIS; EPIDERMAL GROWTH FACTOR RECEPTORS; EPITHELIAL TO MESENCHYMAL TRANSITIONS; FIBROBLAST GROWTH FACTOR; HIER-ARCHICAL CLUSTERING; MULTI VARIATE ANALYSIS; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSFORMING GROWTH FACTORS;

DISEASES;

EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; LONG UNTRANSLATED RNA; TUMOR PROTEIN;

ADULT; AGED; BREAST TUMOR; CELL MOTION; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN GENOME; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, LONG NONCODING;

EID: 85017439631     PISSN: None     EISSN: 23752548     Source Type: Journal    
DOI: 10.1126/sciadv.1600220     Document Type: Article

References (75)

1. J. Ferlay, I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D. M. Parkin, D. Forman, F. Bray, GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 (International Agency for Research on Cancer, Lyon, 2012).
2. C. M. Perou, T. Sørlie, M. B. Eisen, M. van de Rijn, S. S. Jeffrey, C. A. Rees, J. R. Pollack, D. T. Ross, H. Johnsen, L. A. Akslen, Ø. Fluge, A. Pergamenschikov, C. Williams, S. X. Zhu, P. E. Lønning, A.-L. Børresen-Dale, P. O. Brown, D. Botstein, Molecular portraits of human breast tumours. Nature 406, 747–752 (2000).
3. E. Senkus, S. Kyriakides, S. Ohno, F. Penault-Llorca, P. Poortmans, E. Rutgers, S. Zackrisson, F. Cardoso, Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 26 (Suppl. 5), v8–v30 (2015).
4. The. Cancer Genome Atlas Network, Comprehensive molecular portraits of human breast tumours. Nature 490, 61–70 (2012).
5. J. S. Reis-Filho, L. Pusztai, Gene expression profiling in breast cancer: Classification, prognostication, and prediction. Lancet 378, 1812–1823 (2011).
6. th anniversary commentary: Divide and conquer—Breast cancer subtypes and response to therapy. Clin. Cancer Res. 21, 3575–3577 (2015).
7. R. A. Gupta, N. Shah, K. C. Wang, J. Kim, H. M. Horlings, D. J. Wong, M.-C. Tsai, T. Hung, P. Argani, J. L. Rinn, Y. Wang, P. Brzoska, B. Kong, R. Li, R. B. West, M. J. van de Vijver, S. Sukumar, H. Y. Chang, Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071–1076 (2010).
8. J. M. Silva, N. J. Boczek, M. W. Berres, X. Ma, D. I. Smith, LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol. 8, 496–505 (2011).
9. T. Derrien, R. Johnson, G. Bussotti, A. Tanzer, S. Djebali, H. Tilgner, G. Guernec, D. Martin, A. Merkel, D. G. Knowles, J. Lagarde, L. Veeravalli, X. Ruan, Y. Ruan, T. Lassmann, P. Carninci, J. B. Brown, L. Lipovich, J. M. Gonzalez, M. Thomas, C. A. Davis, R. Shiekhattar, T. R. Gingeras, T. J. Hubbard, C. Notredame, J. Harrow, R. Guigó, The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Res. 22, 1775–1789 (2012).
10. T. Gutschner, S. Diederichs, The hallmarks of cancer: A long non-coding RNA point of view. RNA Biol. 9, 703–719 (2012).
11. M. Esteller, Non-coding RNAs in human disease. Nat. Rev. Genet. 12, 861–874 (2011).
12. M. Huarte, M. Guttman, D. Feldser, M. Garber, M. J. Koziol, D. Kenzelmann-Broz, A. M. Khalil, O. Zuk, I. Amit, M. Rabani, L. D. Attardi, A. Regev, E. S. Lander, T. Jacks, J. L. Rinn, A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142, 409–419 (2010).
13. S. W. Cheetham, F. Gruhl, J. S. Mattick, M. E. Dinger, Long noncoding RNAs and the genetics of cancer. Br. J. Cancer 108, 2419–2425 (2013).
14. X. Su, G. G. Malouf, Y. Chen, J. Zhang, H. Yao, V. Valero, J. N. Weinstein, J.-P. Spano, F. Meric-Bernstam, D. Khayat, F. J. Esteva, Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes. Oncotarget 5, 9864–9876 (2014).
15. W. Zhao, J. Luo, S. Jiao, Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications. Sci. Rep. 4, 6591 (2014).
16. L. M. McIntyre, K. K. Lopiano, A. M. Morse, V. Amin, A. L. Oberg, L. J. Young, S. V. Nuzhdin, RNA-seq: Technical variability and sampling. BMC Genomics 12, 293 (2011).
17. N. Raghavachari, J. Barb, Y. Yang, P. Liu, K. Woodhouse, D. Levy, C. J. O’Donnell, P. J. Munson, G. J. Kato, A systematic comparison and evaluation of high density exon arrays and RNA-seq technology used to unravel the peripheral blood transcriptome of sickle cell disease. BMC Med. Genomics 5, 28 (2012).
18. L. Jiang, F. Schlesinger, C. A. Davis, Y. Zhang, R. Li, M. Salit, T. R. Gingeras, B. Oliver, Synthetic spike-in standards for RNA-seq experiments. Genome Res. 21, 1543–1551 (2011).
19. R. Edgar, M. Domrachev, A. E. Lash, Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207–210 (2002).
20. S. Monti, P. Tamayo, J. Mesirov, T. Golub, Consensus clustering: A resampling-based method for class discovery and visualization of gene expression microarray data. Mach. Learn. 52, 91–118 (2003).
21. M. D. Wilkerson, D. N. Hayes, ConsensusClusterPlus: A class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572–1573 (2010).
22. L. Yao, H. Shen, P. W. Laird, P. J. Farnham, B. P. Berman, Inferring regulatory element landscapes and transcription factor networks from cancer methylomes. Genome Biol. 16, 105 (2015).
23. M. Rahman, L. K. Jackson, W. E. Johnson, D. Y. Li, A. H. Bild, S. R. Piccolo, Alternative pre-processing of RNA-sequencing data in The Cancer Genome Atlas leads to improved analysis results. Bioinformatics 31, 3666–3672 (2015).
24. D. Chakravarty, A. Sboner, S. S. Nair, E. Giannopoulou, R. Li, S. Hennig, J. M. Mosquera, J. Pauwels, K. Park, M. Kossai, T. Y. MacDonald, J. Fontugne, N. Erho, I. A. Vergara, M. Ghadessi, E. Davicioni, R. B. Jenkins, N. Palanisamy, Z. Chen, S. Nakagawa, T. Hirose, N. H. Bander, H. Beltran, A. H. Fox, O. Elemento, M. A. Rubin, The oestrogen receptor a-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat. Commun. 5, 5383 (2014).
25. H. Hansji, E. Y. Leung, B. C. Baguley, G. J. Finlay, M. E. Askarian-Amiri, Keeping abreast with long non-coding RNAs in mammary gland development and breast cancer. Front. Genet. 5, 379 (2014).
26. N. C. Turner, J. S. Reis-Filho, A. M. Russell, R. J. Springall, K. Ryder, D. Steele, K. Savage, C. E. Gillett, F. C. Schmitt, A. Ashworth, A. N. Tutt, BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene 26, 2126–2132 (2007).
27. J. L. Rinn, H. Y. Chang, Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 81, 145–166 (2012).
28. M. F. Montenegro, M. D. M. Collado-González, M. P. Fernández-Pérez, M. B. Hammouda, L. Tolordava, M. Gamkrelidze, J. N. Rodríguez-López, Promoting E2F1-mediated apoptosis in oestrogen receptor-a-negative breast cancer cells. BMC Cancer 14, 539 (2014).
29. X. Jiang, D. J. Shapiro, The immune system and inflammation in breast cancer. Mol. Cell. Endocrinol. 382, 673–682 (2014).
30. C. Sweeney, P. S. Bernard, R. E. Factor, M. L. Kwan, L. A. Habel, C. P. Quesenberry, K. Shakespear, E. K. Weltzien, I. J. Stijleman, C. A. Davis, M. T. W. Ebbert, A. Castillo, L. H. Kushi, B. J. Caan, Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: Differences by age, race, and tumor characteristics. Cancer Epidemiol. Biomarkers Prev. 23, 714–724 (2014).
31. L. Zheng, J. Q. Ren, H. Li, Z. L. Kong, H. G. Zhu, Downregulation of wild-type p53 protein by HER-2/neu mediated PI3K pathway activation in human breast cancer cells: Its effect on cell proliferation and implication for therapy. Cell Res. 14, 497–506 (2004).
32. S. Grivennikov, M. Karin, Autocrine IL-6 signaling: A key event in tumorigenesis? Cancer Cell 13, 7–9 (2008).
33. Z. Du, T. Fei, R. G. W. Verhaak, Z. Su, Y. Zhang, M. Brown, Y. Chen, X. S. Liu, Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat. Struct. Mol. Biol. 20, 908–913 (2013).
34. M. W. Wright, A short guide to long non-coding RNA gene nomenclature. Hum. Genomics 8, 7 (2014).
35. Q. Pang, J. Ge, Y. Shao, W. Sun, H. Song, T. Xia, B. Xiao, J. Guo, Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumour Biol. 35, 5441–5447 (2014).
36. M. K. Iyer, Y. S. Niknafs, R. Malik, U. Singhal, A. Sahu, Y. Hosono, T. R. Barrette, J. R. Prensner, J. R. Evans, S. Zhao, A. Poliakov, X. Cao, S. M. Dhanasekaran, Y.-M. Wu, D. R. Robinson, D. G. Beer, F. Y. Feng, H. K. Iyer, A. M. Chinnaiyan, The landscape of long noncoding RNAs in the human transcriptome. Nat. Genet. 47, 199–208 (2015).
37. A. C. Marques, J. Hughes, B. Graham, M. S. Kowalczyk, D. R. Higgs, C. P. Ponting, Chromatin signatures at transcriptional start sites separate two equally populated yet distinct classes of intergenic long noncoding RNAs. Genome Biol. 14, R131 (2013).
38. S. M. Singel, C. Cornelius, E. Zaganjor, K. Batten, V. R. Sarode, D. L. Buckley, Y. Peng, G. B. John, H. C. Li, N. Sadeghi, W. E. Wright, L. Lum, T. W. Corson, J. W. Shay, KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer. Neoplasia 16, 247–256.e2 (2014).
39. Z. Zeng, H. Lin, X. Zhao, G. Liu, X. Wang, R. Xu, K. Chen, J. Li, L. Song, Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor. Clin. Cancer Res. 18, 4059–4069 (2012).
40. R. Keil, J. Schulz, M. Hatzfeld, p0071/PKP4, a multifunctional protein coordinating cell adhesion with cytoskeletal organization. Biol. Chem. 394, 1005–1017 (2013).
41. T. Wakatsuki, R. B. Wysolmerski, E. L. Elson, Mechanics of cell spreading: Role of myosin II. J. Cell Sci. 116, 1617–1625 (2003).
42. D. D. Sarbassov, S. M. Ali, D.-H. Kim, D. A. Guertin, R. R. Latek, H. Erdjument-Bromage, P. Tempst, D. M. Sabatini, Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296–1302 (2004).
43. P. Jonsson, C. Coarfa, F. Mesmar, T. Raz, K. Rajapakshe, J. F. Thompson, P. H. Gunaratne, C. Williams, Single-molecule sequencing reveals estrogen-regulated clinically relevant lncRNAs in breast cancer. Mol. Endocrinol. 29, 1634–1645 (2015).
44. V. Miano, G. Ferrero, S. Reineri, L. Caizzi, L. Annaratone, L. Ricci, S. Cutrupi, I. Castellano, F. Cordero, M. De Bortoli, Luminal long non-coding RNAs regulated by estrogen receptor a in a ligand-independent manner show functional roles in breast cancer. Oncotarget 7, 3201–3216 (2016).
45. Y.-Y. Tseng, B. S. Moriarity, W. Gong, R. Akiyama, A. Tiwari, H. Kawakami, P. Ronning, B. Reuland, K. Guenther, T. C. Beadnell, J. Essig, G. M. Otto, M. G. O’Sullivan, D. A. Largaespada, K. L. Schwertfeger, Y. Marahrens, Y. Kawakami, A. Bagchi, PVT1 dependence in cancer with MYC copy-number increase. Nature 512, 82–86 (2014).
46. G. Doose, A. Haake, S. H. Bernhart, C. López, S. Duggimpudi, F. Wojciech, A. K. Bergmann, A. Borkhardt, B. Burkhardt, A. Claviez, L. Dimitrova, S. Haas, J. I. Hoell, M. Hummel, D. Karsch, W. Klapper, K. Kleo, H. Kretzmer, M. Kreuz, R. Küppers, C. Lawerenz, D. Lenze, M. Loeffler, L. Mantovani-Löffler, P. Möller, G. Ott, J. Richter, M. Rohde, P. Rosenstiel, A. Rosenwald, M. Schilhabel, M. Schneider, I. Scholz, S. Stilgenbauer, H. G. Stunnenberg, M. Szczepanowski, L. Trümper, M. A. Weniger; ICGC MMML-Seq Consortium, S. Hoffmann, R. Siebert, I. Iaccarino, MINCR is a MYC-induced lncRNA able to modulate MYC’s transcriptional network in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. U.S.A. 112, E5261–E5270 (2015).
47. E. M. Ciruelos Gil, Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer. Cancer Treat. Rev. 40, 862–871 (2014).
48. M. C. Louie, A. McClellan, C. Siewit, L. Kawabata, Estrogen receptor regulates E2F1 expression to mediate tamoxifen resistance. Mol. Cancer Res. 8, 343–352 (2010).
49. V. Vuaroqueaux, P. Urban, M. Labuhn, M. Delorenzi, P. Wirapati, C. C. Benz, R. Flury, H. Dieterich, F. Spyratos, U. Eppenberger, S. Eppenberger-Castori, Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome. Breast Cancer Res. 9, R33 (2007).
50. E. M. Curran, B. M. Judy, N. A. Duru, H.-Q. Wang, L. A. Vergara, D. B. Lubahn, D. M. Estes, Estrogenic regulation of host immunity against an estrogen receptor–negative human breast cancer. Clin. Cancer Res. 12, 5641–5647 (2006).
51. A. A. Mostafa, D. Codner, K. Hirasawa, Y. Komatsu, M. N. Young, V. Steimle, S. Drover, Activation of ERa signaling differentially modulates IFN-g induced HLA-class II expression in breast cancer cells. PLOS One 9, e87377 (2014).
52. N. J. Sullivan, A. K. Sasser, A. E. Axel, F. Vesuna, V. Raman, N. Ramirez, T. M. Oberyszyn, B. M. Hall, Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells. Oncogene 28, 2940–2947 (2009).
53. Z. T. Schafer, J. S. Brugge, IL-6 involvement in epithelial cancers. J. Clin. Invest. 117, 3660–3663 (2007).
54. N. Berteaux, N. Aptel, G. Cathala, C. Genton, J. Coll, A. Daccache, N. Spruyt, H. Hondermarck, T. Dugimont, J.-J. Curgy, T. Forné, E. Adriaenssens, A novel H19 antisense RNA overexpressed in breast cancer contributes to paternal IGF2 expression. Mol. Cell. Biol. 28, 6731–6745 (2008).
55. E. Adriaenssens, L. Dumont, S. Lottin, D. Bolle, A. Leprêtre, A. Delobelle, F. Bouali, T. Dugimont, J. Coll, J.-J. Curgy, H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression. Am. J. Pathol. 153, 1597–1607 (1998).
56. L. Zhang, F. Yang, J.-H. Yuan, S.-X. Yuan, W.-P. Zhou, X.-S. Huo, D. Xu, H.-S. Bi, F. Wang, S.-H. Sun, Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis 34, 577–586 (2013).
57. R. Bergström, K. Savary, A. Morén, S. Guibert, C.-H. Heldin, R. Ohlsson, A. Moustakas, Transforming growth factor b promotes complexes between Smad proteins and the CCCTC-binding factor on the H19 imprinting control region chromatin. J. Biol. Chem. 285, 19727–19737 (2010).
58. I. J. Matouk, E. Raveh, R. Abu-lail, S. Mezan, M. Gilon, E. Gershtain, T. Birman, J. Gallula, T. Schneider, M. Barkali, C. Richler, Y. Fellig, V. Sorin, A. Hubert, A. Hochberg, A. Czerniak, Oncofetal H19 RNA promotes tumor metastasis. Biochim. Biophys. Acta 1843, 1414–1426 (2014).
59. C. Chen, Z. Li, Y. Yang, T. Xiang, W. Song, S. Liu, Microarray expression profiling of dysregulated long non-coding RNAs in triple-negative breast cancer. Cancer Biol. Ther. 16, 856–865 (2015).
60. X.-H. Liu, M. Sun, F.-Q. Nie, Y.-B. Ge, E.-B. Zhang, D.-D. Yin, R. Kong, R. Xia, K.-H. Lu, J.-H. Li, W. De, K.-M. Wang, Z.-X. Wang, Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol. Cancer 13, 92 (2014).
61. G. Yang, S. Zhang, F. Gao, Z. Liu, M. Lu, S. Peng, T. Zhang, F. Zhang, Osteopontin enhances the expression of HOTAIR in cancer cells via IRF1. Biochim. Biophys. Acta 1839, 837–848 (2014).
62. Z. Hui, M. Xianglin, Association of HOTAIR expression with PI3K/Akt pathway activation in adenocarcinoma of esophagogastric junction. Open Med. 11, 36–40 (2016).
63. J. Zhou, X. Zhi, L. Wang, W. Wang, Z. Li, J. Tang, J. Wang, Q. Zhang, Z. Xu, Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway. J. Exp. Clin. Cancer Res. 34, 135 (2015).
64. J. Ji, J. Tang, L. Deng, Y. Xie, R. Jiang, G. Li, B. Sun, LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway. Oncotarget 6, 42813–42824 (2015).
65. K. L. Scott, O. Kabbarah, M.-C. Liang, E. Ivanova, V. Anagnostou, J. Wu, S. Dhakal, M. Wu, S. Chen, T. Feinberg, J. Huang, A. Saci, H. R. Widlund, D. E. Fisher, Y. Xiao, D. L. Rimm, A. Protopopov, K.-K. Wong, L. Chin, GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature 459, 1085–1090 (2009).
66. Y. Gökmen-Polar, I. T. Vladislav, Y. Neelamraju, S. C. Janga, S. Badve, Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancers. Sci. Rep. 5, 8765 (2015).
67. J. Sun, X. Chen, Z. Wang, M. Guo, H. Shi, X. Wang, L. Cheng, M. Zhou, A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients. Sci. Rep. 5, 16553 (2015).
68. K. P. Sørensen, M. Thomassen, Q. Tan, M. Bak, S. Cold, M. Burton, M. J. Larsen, T. A. Kruse, Long non-coding RNA expression profiles predict metastasis in lymph node-negative breast cancer independently of traditional prognostic markers. Breast Cancer Res. 17, 55 (2015).
69. P.-J. Volders, K. Helsens, X. Wang, B. Menten, L. Martens, K. Gevaert, J. Vandesompele, P. Mestdagh, LNCipedia: A database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res. 41, D246–D251 (2013).
70. P. Stępniak, M. Maycock, K. Wojdan, M. Markowska, S. Perun, A. Srivastava, L. S. Wyrwicz, K. Świrski, Microarray Inspector: Tissue cross contamination detection tool for microarray data. Acta Biochim. Pol. 60, 647–655 (2013).
71. J. S. Parker, M. Mullins, M. C. U. Cheang, S. Leung, D. Voduc, T. Vickery, S. Davies, C. Fauron, X. He, Z. Hu, J. F. Quackenbush, I. J. Stijleman, J. Palazzo, J. S. Marron, A. B. Nobel, E. Mardis, T. O. Nielsen, M. J. Ellis, C. M. Perou, P. S. Bernard, Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27, 1160–1167 (2009).
72. C. W. Law, Y. Chen, W. Shi, G. K. Smyth, voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).
73. M. E. Ritchie, B. Phipson, D. Wu, Y. Hu, C. W. Law, W. Shi, G. K. Smyth, limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
74. D. Venet, J. E. Dumont, V. Detours, Most random gene expression signatures are significantly associated with breast cancer outcome. PLOS Comput. Biol. 7, e1002240 (2011).
75. P. Du, W. A. Kibbe, S. M. Lin, lumi: A pipeline for processing Illumina microarray. Bioinformatics 24, 1547–1548 (2008).